Sevelamer in Proteinuric CKD

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Chronic Kidney Disease
Interventions
DRUG

Sevelamer

DRUG

Ramipril and Irbesartan

Trial Locations (2)

24020

Clinical Research Center for Rare Diseases, Ranica

Unknown

"Azienda Ospedaliera Bianchi-Melacrino-Morelli c/o Ospedali Riuniti U.O. Nefrologia, Dialisi e Trapianto", Reggio Calabria

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT01968759 - Sevelamer in Proteinuric CKD | Biotech Hunter | Biotech Hunter